Science and reality
Editas Medicine, an upstart hoping to treat patients by correcting their genes, went public yesterday. But the company already faces several concerns---most pressingly, a patent battle.
The post Crispr Gene-Editing Upstart Editas Goes Public as Patent Battle Rages appeared first on WIRED.
The editors of the academic journal Lingua quit to protest high fees from publisher Elsevier.
The post Editors of the Journal Lingua Protest-Quit in Battle for Open Access appeared first on WIRED.
The FDA approved the first drug in the United States that can be prescribed to treat a woman's low sex drive. But critics aren't so sure we need it.
The post FDA Approves the First ‘Female Viagra’ appeared first on WIRED.